Drugs that contain Lemborexant
1. Drug name - DAYVIGO
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8268848 | EISAI INC | Cyclopropane compound |
Sep, 2031
(8 years from now) | |
| CN103153963B | EISAI INC | Cyclopropane Compound |
Sep, 2031
(8 years from now) | |
| CN103153963A | EISAI INC | Cyclopropane Compound |
Sep, 2031
(8 years from now) | |
| IN387588B | EISAI INC | Cyclopropane Compound |
Sep, 2031
(8 years from now) | |
| IN201303338P1 | EISAI INC | Cyclopropane Compound |
Sep, 2031
(8 years from now) | |
| EP2626350A4 | EISAI INC | Cyclopropane Compound |
Sep, 2031
(8 years from now) | |
| EP2626350B1 | EISAI INC | Cyclopropane Compound |
Sep, 2031
(8 years from now) | |
| EP2626350A1 | EISAI INC | Cyclopropane Compound |
Sep, 2031
(8 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10188652 | EISAI INC | Compositions and methods for treating insomnia |
Oct, 2035
(13 years from now) | |
Treatment: Treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 5MG | TABLET;ORAL | Prescription |
| 10MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.